Records by Year Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date, Ferring Pharmaceuticals and its 1 subsidiaries
1 2017 Records1
1 2018 2018 Records1 vs 2017+0
0 2019 Records0 vs 2018−1
4 2020 2020 Records4 vs 2019+4
3 2021 Records3 vs 2020−1
0 2022 2022 Records0 vs 2021−3
1 2023 Records1 vs 2022+1
0 2024 2024 Records0 vs 2023−1
0 2025 Records0 vs 2024+0
1 2026 2026 to date Records1
Latest Records Newest first across sources; each opens the record Date Record Source Feb 27, 2026 Complete response letter, BLA 761253 Unapproved Complete response letters Jun 12, 2023 Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal applicators, Manufactu Class II · cGMP deviations: potential for Microbial Contamination of Non-Sterile Products Drug recalls Mar 11, 2021 ZOMA-Jet 10 Demonstration Kit, Needle-free delivery device for use with ZOMACTON (somatropin) for injection 10 mg vial, ZOMA-Jet 10 Demonstr Class II · Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces Drug recalls Mar 11, 2021 ZOMA-Jet 5 Demonstration Kit, Needle-free delivery device for use with ZOMACTON (somatropin) for injection 5mg vial, Rx only, ZOMA-Jet 5 Dem Class II · Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces Drug recalls Mar 2, 2021 Menopur 75 IU, (menotropins for injection), packaged as a) 5 single dose vials of Menotropins for injection, 5 single dose vials of 0.9% Sod Class III · Failed pH specifications: Out of Specification pH results for 0.9% Sodium Chloride, USP Drug recalls Jul 21, 2020 STIMATE (desmopressin acetate) Nasal Spray1.5 mg/mL, 2.5 mL glass vial with spray cap, Rx only, Manufactured for: CSL Behring LLC, King of P Class I · Superpotent Drug Drug recalls Jul 21, 2020 Desmopressin Acetate Nasal Spray 10 mcg/0.1 mL, 5mL glass vial with spray cap, Rx only, Manufactured for: AMRING PHARMACEUTICALS INC., Berwy Class I · Superpotent Drug Drug recalls Jul 21, 2020 DDAVP Nasal Spray (desmopressin acetate) 10 mcg/0.1 mL, 5 mL bottles, Rx Only, Mfd for: Ferring Pharmaceuticals Inc., Parsippany, NJ 07054 U Class I · Superpotent Drug Drug recalls Nov 23, 2016 Complete response letter, NDA 201110 Approved Complete response letters Sep 9, 2015 Bravelle 75 IU (urofollitropin for injection, purified) For Subcutaneous or Intramuscular Injection Only, 1 Carton (contains 5 single dose v Class III · Subpotent Drug Drug recalls Jan 30, 2015 Complete response letter, NDA 022517 Approved Complete response letters Jan 30, 2013 Complete response letter, NDA 022517 Approved Complete response letters Apr 22, 2010 Complete response letter, NDA 022517 Approved Complete response letters Feb 28, 1989 BT-1 INFUSION PUMP K881759 · FRN 510(k) clearances Jun 15, 1983 PULSAMAT MODEL 1050 K830906 · FRN 510(k) clearances
Subsidiaries and Divisions 1 firms in the Ferring Pharmaceuticals group, most records first
Canada and Imports Across the Ferring Pharmaceuticals group, matched by company name Active Health Canada device licences 1 , as of Nov 10, 2026FDA import refusals since 2024 4 shipment lines, through Oct 23, 2026
Names and Identifiers
Appears as Ferring Pharmaceuticals Inc FERRING PHARMS INC Ferring Pharmaceuticals Inc. Ferring Pharmaceuticals, Inc. FERRING Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built